Drugs Controller General of India (DCGI) V.G. Somani has gave permission to Serum Institute of India (SII) to resume clinical trial of the Oxford COV
from The Hindu - National https://ift.tt/3c0iBqr
Tuesday, September 15, 2020
Serum Institute gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine https://ift.tt/eA8V8J
Related Posts:
About 400 million workers in India may sink into poverty: UN report
https://ift.tt/eA8V8J- COVID-19 | 60 fresh cases reported in Maharashtra
https://ift.tt/eA8V8J
- Shab-e-Barat: Congregations banned in Srinagar, restrictions on movement of people
https://ift.tt/eA8V8J
- ‘Sakhi Mandals’ in Jharkhand use medicinal plants in hand sanitizers
https://ift.tt/eA8V8J
- 14-month-old boy dies due to coronavirus in Gujarat’s Jamnagar
https://ift.tt/eA8V8J
0 comments:
Post a Comment